Moderna could strike gold when it comes to its COVID-19 vaccine candidate – or it could flop. Either way, the under-the-radar “picks-and-shovels” stock highlighted in today’s article – one that has become a central player in helping Moderna and other drugmakers develop their respective COVID-19 vaccines and therapeutics – stands to benefit. So might this stock actually be a better COVID-19 play than Moderna itself? CLICK HERE.